Tailored Home-Based Exercise Program for Multiple Chronic Conditions
iHBE
Assessment of a Tailored Home-Based Exercise Program on Symptoms, Well-Being, and Resilience Among Cancer Survivors With Multiple Chronic Conditions
3 other identifiers
interventional
34
1 country
1
Brief Summary
A home-based, tailored, technology-enhanced home-based exercise program (iHBE) using a combination of the integrated mobile technologies (wearable device and phone application) and tailored home-based exercise will be pilot tested. Participants will choose one of the four home-based exercise options \[National Institute of Aging (NIA) Go4Life (an exercise and physical activity campaign from the NIA), Iyengar-style yoga, walking, and modified Otago exercise\] based on participants' preference and goals. The integrated mobile technologies system will allow the investigators to extract heart rate data directly from the wearable device to the research server. This data will be used to provide appropriate and personalized feedback on physical performance. The survey and notification to the participants on the smartphone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2019
CompletedFirst Posted
Study publicly available on registry
March 14, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedResults Posted
Study results publicly available
September 21, 2022
CompletedOctober 14, 2025
September 1, 2025
1.5 years
March 12, 2019
July 19, 2022
September 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Fatigue as Assessed by Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0-Fatigue 6a
Fatigue was assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0-Fatigue 6a. This 6-item measure covers fatigue frequency, duration, intensity, and impact on daily activities. Responses were summed to generate a raw score (range 6-30), which was converted to a standardized T-score (mean = 50, SD = 10) based on the U.S. general population. Higher T-scores indicate greater fatigue (worse outcome). The reported outcome is the change in PROMIS Fatigue T-score from baseline to completion, where negative values indicate improvement.
Pre- and post-intervention, up to 12 weeks
Change in Resilience as Assessed by Connor-Davidson Resilience Scale
Resilience was assessed using the Connor-Davidson Resilience Scale (CD-RISC; 10 items). Each item is rated on a 5-point Likert scale (0 = not true at all to 4 = true nearly all the time). Raw scores are summed to produce a total score ranging from 0 to 40, with higher scores indicating greater resilience (better outcome). The reported outcome is the mean change in raw score, calculated as the score at the completion time point (12 weeks) minus the score at baseline. Positive values indicate improvement in resilience.
Pre- and post-intervention, up to 12 weeks
Change in Physical Well Being
Physical well-being was assessed using the 36-Item Short Form Health Survey (SF-36). The measure was derived from the physical functioning, role-physical, and bodily pain domains. Each domain is scored from 0 to 100, with higher scores indicating better physical health. The reported outcome is the mean change in the averaged domain scores from baseline to completion. Positive values indicate improvement in physical well-being.
Pre- and post-intervention, up to 12 weeks
Change in Mental Well Being
Mental well-being was assessed using the 36-Item Short Form Health Survey (SF-36). The Mental Component Score was calculated as the average of relevant domains (vitality, social functioning, role limitations due to emotional health, and mental health). Each domain is scored from 0 to 100, and the average domain score was used to represent overall mental well-being. Higher scores indicate better mental health. The reported outcome is the mean change in the averaged raw score from baseline to completion. Positive values indicate an improvement in mental well-being.
Pre- and post-intervention, up to 12 weeks
Secondary Outcomes (3)
Physical Activity
12 weeks
Change in Brain-Derived Neurotrophic Factor Level (in Serum)
Pre-and post-intervention, up to 12 weeks
Change in Brain-Derived Neurotrophic Factor Level (in Sweat)
Pre- and post-intervention, up to 12 weeks
Study Arms (2)
The iHBE program group
EXPERIMENTALTailored Technology-Enhance Home-based exercise program (iHBE)
Usual Care (Control group)
NO INTERVENTIONParticipants were required to wear physical activity tracker (Fitbit) and respond to the daily symptoms survey (mEMA) while receiving usual care
Interventions
The tailored technology enhanced home-based exercise (iHBE) program is a 12-week program with 1 assessment home visit session, 5 home visits and 7 phone follow ups during exercise. The technologies, a wearable device, and a smartphone application, will be used as a tool to monitor physical performance (heart rate \[HR\], step count), provide immediate feedback, send daily reminding message through Mobile Ecological Momentary Assessment (mEMA). The coded raw data without personal identification information from the wearable device will be sent to the servers where the investigators can store it in the database alongside the mEMA data and create custom reports showing Heart Rate (HR) 30 minute before each Ecological Momentary Assessment (EMA) survey, showing HR and previous self-report responses before/ after each automatically triggered EMA.
Eligibility Criteria
You may qualify if:
- participants diagnosed with solid tumor cancer who have completed cancer treatment at least 6 months;
- diagnosed with diabetes and/or hypertension for at least a year;
- aged 21 years or older,
- have an annual household incomes of below $50,000 for families of three,
- the average fatigue level within the past 7 days at the level of 3 or more on the 0 (no fatigue) to 10 (worse fatigue) Likert scale
- give informed consent.
You may not qualify if:
- currently undergoing treatment for cancer;
- have an active infection (e.g., fever, localized redness, swelling, sinus congestion);
- diagnosed with a psychological disorder (e.g., suicidal or homicidal tendencies, extreme anxiety or depression)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study was interrupted by the COVID-19 pandemic, which led to unanticipated pauses in study activities and affected participant enrollment, intervention delivery, and follow-up assessments. As a result, the sample size was smaller than originally planned and some study procedures were modified. These factors may limit the generalizability of the findings and the ability to fully determine the intervention's effect.
Results Point of Contact
- Title
- Nada Lukkahatai
- Organization
- Johns Hopkins School of Nursing
Study Officials
- PRINCIPAL INVESTIGATOR
Nada Lukkahatai, PhD
Johns Hopkins School of Nursing
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single blinded marking: The data collectors are blinded to the group allocation
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2019
First Posted
March 14, 2019
Study Start
August 1, 2019
Primary Completion
January 31, 2021
Study Completion
June 30, 2021
Last Updated
October 14, 2025
Results First Posted
September 21, 2022
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
The individual participant data (IPD) will not be shared with other researchers